Karyopharm Therapeutics has reached a significant milestone by completing patient enrolment for its Phase III SENTRY trial.

PhaseV has entered into a strategic partnership with Bioforum to enhance the efficiency of clinical trials using advanced ...

Amidst significant shifts in the pharmaceutical industry, the number of clinical trials has surged over the first half of ...

These readouts will help Regeneron structure the confirmatory trials for the two allergy combination therapies.

As the IASLC 2025 World Conference on Lung Cancer approaches, CTA looks at some of the most promising NSCLC assets in Phase ...

AstraZeneca's Tagrisso, in combination with pemetrexed and platinum-based chemotherapy, has shown a significant improvement ...

Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) ...

On this episode, the healthcare editorial team unpicks several key trials and trends from this year’s event, held from 29 August to 1 September in Madrid. Data at ESC is from studies evaluating ...

Revolution will now explore daraxonrasib’s potential as a monotherapy and in combination with chemotherapy in late-stage PDAC trials.

Takeda’s readout comes from two pivotal Phase III trials of its OX2R, with Alkermes’ data coming from a Phase II trial in NT1 ...

RealTime eClinical Solutions has rolled out the TrialAlign platform that aims to refine the performance analytics for ...

In August, Regeneron announced positive results from Phase III clinical trial NIMBLE evaluating the efficacy and safety of pozelimab + cemdisiran combination therapy and cemdisiran monotherapy for ...